Guardant Health, Inc. (GH) — Business segments and KPIs
Revenue by business segment and geography for Guardant Health, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Oncology | 683.6M | 69.6% |
| Biopharma & Data | 210.13M | 21.4% |
| Screening | 79.73M | 8.1% |
| Licensing & Other | 8.56M | 0.9% |
| Revenue by region | ||
| UNITED STATES | 923.28M | 94.0% |
| Non-US | 58.74M | 6.0% |